IL-1ß and iNOS can drive the asthmatic comorbidities and decrease of lung function in perennial allergic rhinitis children.

ABSTRACT

BACKGROUND: Allergic asthma and rhinitis (AR) are closely linked, with a significant proportion of AR patients developing asthma. Identification of the early signs of comorbidity of AR and asthma can enable prompt treatment and prevent asthma progression. OBJECTIVES AND METHODS: This study investigated the role of interleukin-1ß (IL-1ß), a pro-inflammatory cytokine, and inducible nitric oxide synthase (iNOS) in the comorbidity of AR and asthma and lung function in Korean children with perennial AR (PAR). A cohort of 240 subjects (6 to 10 years old) with PAR (PAR alone 113 children, PAR and asthma 127 children) was analyzed for various biomarkers, including IL-1ß, iNOS, and epithelial-mesenchymal transition (EMT) markers in serum. The blood levels of eosinophils and immunoglobulin E (IgE) were examined. IL-1ß, CCL-24, E-cadherin, and vimentin were measured by enzyme-linked immunosorbent assay (ELISA). Epithelial iNOS was measured by the NOS kit. RESULTS: Elevated levels of IL-1ß, iNOS, and vimentin in the serum were identified as significant indicators of the likelihood of comorbidity of PAR and asthma in children. Furthermore, higher concentrations of IL-1ß, iNOS, and vimentin have been linked to reduced lung function in PAR children. Notably, IL-1ß expression shows a relationship with the levels of E-cadherin, vimentin, and CCL-24. However, no correlation was found between IL-1ß and iNOS expressions. CONCLUSIONS: This study suggests that IL-1ß and iNOS can be biomarkers in the progression of PAR and asthma and decreased lung function, suggesting potential targets for early intervention and treatment.